CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-21 | Wolff Allen CFO and EVP | Shares withheld for taxes | −141 | $3.47 | $489 | 58,429 |
| 2019-06-21 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −34 | $3.47 | $118 | 9,844 |
| 2019-06-21 | Krishnan Ram CEO | Shares withheld for taxes | −235 | $3.47 | $815 | 102,856 |
| 2019-06-07 | Thomas Gregory Matthew Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2019-06-07 | Simtob Richard Isaac Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2019-06-07 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2019-06-07 | Yanover Paul Director | Grant or award · Stock Options (Right to Buy) | +400 | 400 | ||
| 2019-05-21 | Krishnan Ram CEO | Shares withheld for taxes | −234 | $2.89 | $676 | 103,091 |
| 2019-05-21 | Wolff Allen CFO and EVP | Shares withheld for taxes | −171 | $2.89 | $494 | 58,570 |
| 2019-05-21 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −35 | $2.89 | $101 | 9,878 |
| 2019-04-23 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −34 | $3.80 | $129 | 9,913 |
| 2019-04-23 | Wolff Allen CFO and EVP | Shares withheld for taxes | −171 | $3.80 | $650 | 58,741 |
| 2019-04-23 | Krishnan Ram CEO | Shares withheld for taxes | −277 | $3.80 | $1K | 103,325 |
| 2019-03-26 | Gurrola Sandra M VP of Finance | Shares withheld for taxes | −34 | $3.72 | $126 | 9,947 |
| 2019-03-26 | Wolff Allen CFO and EVP | Shares withheld for taxes | −171 | $3.72 | $636 | 58,912 |
| 2019-03-26 | Krishnan Ram CEO | Shares withheld for taxes | −284 | $3.72 | $1K | 103,603 |
| 2019-03-19 | Wolff Allen CFO and EVP | Grant or award | +10,000 | 59,083 | ||
| 2019-03-19 | Gurrola Sandra M VP of Finance | Grant or award | +7,000 | 9,981 | ||
| 2019-03-19 | Krishnan Ram CEO | Grant or award | +30,000 | 103,887 | ||
| 2019-02-26 | Wolff Allen CFO and EVP | Shares withheld for taxes | −171 | $3.42 | $585 | 49,083 |
Page 13 of 33 · 657 trades